High-Dose Methotrexate-Induced Dermatological Eruption: A Rare Manifestation of Chemotoxicity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
High-Dose Methotrexate-Induced Dermatological Eruption: A Rare Manifestation of Chemotoxicity ; volume:43 ; number:05 ; year:2022 ; pages:431-433
Indian journal of medical & paediatric oncology ; 43, Heft 05 (2022), 431-433
- Beteiligte Personen und Organisationen
-
Mathiyazhagan, Gopinathan
Aggarwal, Shilpi
Chauhan, Priyanka
Gupta, Anshul
Kashyap, Rajesh
- DOI
-
10.1055/s-0042-1748939
- URN
-
urn:nbn:de:101:1-2022121512021098861211
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mathiyazhagan, Gopinathan
- Aggarwal, Shilpi
- Chauhan, Priyanka
- Gupta, Anshul
- Kashyap, Rajesh
Ähnliche Objekte (12)
High-dose Methotrexate
High-dose methotrexate : pharmacokinetics in children and young adults
High-dose methotrexate in ICU patients: a retrospective study
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy
Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
Periprosthetic seromas and a third space effect after high-dose methotrexate
Dermatological thermography
Acute Kidney Injury Following High-Dose Methotrexate Administration in a Day Care Hospital
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
High-dose Methotrexate
High-dose methotrexate : pharmacokinetics in children and young adults
High-dose methotrexate in ICU patients: a retrospective study
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy
Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
Periprosthetic seromas and a third space effect after high-dose methotrexate
Dermatological thermography
Acute Kidney Injury Following High-Dose Methotrexate Administration in a Day Care Hospital
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
High-dose Methotrexate
High-dose methotrexate : pharmacokinetics in children and young adults
High-dose methotrexate in ICU patients: a retrospective study
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy
Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
Periprosthetic seromas and a third space effect after high-dose methotrexate
Dermatological thermography
Acute Kidney Injury Following High-Dose Methotrexate Administration in a Day Care Hospital
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)